CTNM · NASDAQ · Biotechnology

Contineum Therapeutics (CTNM)

Discovers and develops oral small-molecule therapies for neuroscience, inflammation and immunology.

$12.81
vs last close−0.59 (−4.41%)

Something off on this page? Send us feedback.

Next report
Oct 29, 26
estimated · in 36 days
EPS estimate
−$0.45
Revenue estimate
$5.7M
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Mar '25May '25Aug '25Oct '25Mar '26May '26Jul '26Oct '26
Reported−$0.56−$0.62−$0.62−$0.45−$0.49−$0.39−$0.40Pending
Estimate−$0.44−$0.56−$0.56−$0.58−$0.50−$0.55−$0.45−$0.45
Surprise−27.3%−10.7%−10.7%+22.4%+2.0%+29.1%+10.9%

RevenueReportedEstimate

Mar '25May '25Aug '25Oct '25Mar '26May '26Jul '26Oct '26
ReportedPending
Estimate$6.0M$7.5M$5.0M$7.5M$5.7M
Surprise

HistoryUpcoming

Date / PeriodEstimateReportedSurprise
Dec 2028−$0.34
Sep 2028−$0.34
Jun 2028−$0.34
Mar 2028−$0.33
Dec 2027−$0.51
Sep 2027−$0.47
Jun 2027−$0.47
Mar 2027−$0.46
Dec 2026−$0.46
Oct 2026−$0.45
Jul 2026−$0.45−$0.40+10.9%
May 2026−$0.55−$0.39+29.1%
Mar 2026−$0.50−$0.49+2.0%
Oct 2025−$0.58−$0.45+22.4%
Aug 2025
May 2025
Mar 2025
Nov 2024
Aug 2024
May 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Dec 2022

The latest year is open to everyone — the 12 quarters behind it read with an account.

Date / PeriodEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
Dec 2028−$0.34$0
Sep 2028−$0.34$0
Jun 2028−$0.34$0
Mar 2028−$0.33$0
Dec 2027−$0.51$0
Sep 2027−$0.47$0
Jun 2027−$0.47$0
Mar 2027−$0.46$0
Dec 2026−$0.46$10.0M
Oct 29, 2026−$0.45$5.7M
Jul 30, 2026−$0.45−$0.40+10.9%−1.7%
May 5, 2026−$0.55−$0.39+29.1%+1.7%
Mar 5, 2026−$0.50−$0.49+2.0%$7.5M−7.1%
Oct 30, 2025−$0.58−$0.45+22.4%$5.0M−3.3%
Aug 5, 2025
May 14, 2025
Mar 6, 2025
Nov 6, 2024
Aug 13, 2024
May 16, 2024
Mar 15, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022

The latest year is open to everyone — the 12 quarters behind it read with an account.